YD Bio Limited Deferred Income Tax Expense (Benefit)
YD Bio Limited (YDES) reported Deferred Income Tax Expense (Benefit) of -$1.46 thousand for the 12-month period ending 2025-12-31, per its POS AM filed 2026-05-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-05-26
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$1.46K POS AM · filed 2026-05-26 |
| 2024-12-31 | $26.58K POS AM · filed 2026-05-26 |
| 2023-12-31 | $4.09K POS AM · filed 2026-05-26 |